GW Cancer Center Researchers Find Potential Therapeutic Target for Prostate Cancers with PTEN Mutation
PTEN, a tumor suppressor gene mutated in about 20% of prostate cancers, relies on another gene, ARID4B, to function. These findings were published by George Washington University Cancer Center researchers in Nature Communications.
Read more